Innovative drugs and CRO concept stocks are once again on the rise, with Beilu Pharmaceutical up more than 10%.

Northern pharmaceutical industry rose by more than 10%, Guangshengtang, Yuekang Pharmaceutical, Wanbang Medicine, Jinshiya Medicine, Boji Medicine, and Shutaishen and other stocks rose by more than 5%. In terms of news, the State Drug Administration has organized the drafting of the "Notice on Optimizing the Clinical Trial Review and Approval of Innovative Drugs", which mentioned that in order to further support the research and development of innovative drugs based on clinical value orientation and improve the quality and effectiveness of clinical research and development, the review and approval of clinical trial applications for qualified innovative drugs should be completed within 30 working days.